Craving in opioid use disorder: from neurobiology to clinical practice

J Kakko, H Alho, A Baldacchino, R Molina… - Frontiers in …, 2019 - frontiersin.org
Opioid use disorder (OUD) is a major public health issue that has reached epidemic levels
in some parts of the world. It is a chronic and complex neurobiological disease associated …

Catecholamines in post-traumatic stress disorder: a systematic review and meta-analysis

X Pan, AC Kaminga, SW Wen, A Liu - Frontiers in molecular …, 2018 - frontiersin.org
Studies on the association between post-traumatic stress disorder (PTSD) and levels of
catecholamines have yielded inconsistent results. The aim of this study was to conduct a …

Gut microbes participate in food preference alterations during obesity

A de Wouters d'Oplinter, M Rastelli, M Van Hul… - Gut …, 2021 - Taylor & Francis
Hypothalamic regulations of food intake are altered during obesity. The dopaminergic
mesocorticolimbic system, responsible for the hedonic response to food intake, is also …

Pathophysiology linking depression and type 2 diabetes: psychotherapy, physical exercise, and fecal microbiome transplantation as damage control

R Subba, R Sandhir, SP Singh… - European Journal of …, 2021 - Wiley Online Library
Diabetes increases the likelihood of developing depression and vice versa. Research on
this bidirectional association has somewhat managed to delineate the interplay among …

Drug choices and advancements for managing depression in Parkinson's disease

F Assogna, C Pellicano, C Savini… - Current …, 2020 - ingentaconnect.com
Depression is a frequent non-motor symptom of Parkinson's disease (PD), and may even
precede the onset of motor symptoms of parkinsonism. Beyond its negative influence on …

[HTML][HTML] The relationship between plasma serotonin and kynurenine pathway metabolite levels and the treatment response to escitalopram and desvenlafaxine

Y Sun, W Drevets, G Turecki, QS Li - Brain, Behavior, and Immunity, 2020 - Elsevier
Introduction The response of patients with major depressive disorders (MDD) to
antidepressant treatments have been shown to be affected by multiple factors, including …

Reward Deficiency Syndrome (RDS): a cytoarchitectural common neurobiological trait of all addictions

K Blum, A Bowirrat, ER Braverman, D Baron… - International Journal of …, 2021 - mdpi.com
Alcohol and other substance use disorders share comorbidity with other RDS disorders, ie, a
reduction in dopamine signaling within the reward pathway. RDS is a term that connects …

The therapeutic potential of exercise for neuropsychiatric diseases: A review

S Swenson, K Blum, T McLaughlin, MS Gold… - Journal of the …, 2020 - Elsevier
Exercise is known to have a myriad of health benefits. There is much to be learned from the
effects of exercise and its potential for prevention, attenuation and treatment of multiple …

[HTML][HTML] Biotechnical development of genetic addiction risk score (GARS) and selective evidence for inclusion of polymorphic allelic risk in substance use disorder …

K Blum, A Bowirrat, D Baron, L Lott… - Journal of systems …, 2020 - ncbi.nlm.nih.gov
Research into the neurogenetic basis of addiction identified and characterized by Reward
Deficiency Syndrome (RDS) includes all drug and non-drug addictive, obsessive and …

The first exploratory personalized medicine approach to improve bariatric surgery outcomes utilizing psychosocial and genetic risk assessments: encouraging clinical …

PK Thanos, C Hanna, A Mihalkovic… - Journal of Personalized …, 2023 - mdpi.com
It is predicted that by 2030, globally, an estimated 2.16 billion adults will be overweight, and
1.12 billion will be obese. This study examined genetic data regarding Reward Deficiency …